Cargando…
CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
Pituitary tumors are monoclonal adenomas that account for about 10-15% of intracranial tumors. Cyclin-dependent kinase 5 (CDK5) regulates the activities of various proteins and cellular processes in the nervous system, but its potential roles in pituitary adenomas are poorly understood. The kinase a...
Autores principales: | Xie, Weiyan, Wang, Hongyun, He, Yue, Li, Dan, Gong, Lei, Zhang, Yazhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927131/ https://www.ncbi.nlm.nih.gov/pubmed/24550687 http://dx.doi.org/10.7150/ijbs.7770 |
Ejemplares similares
-
Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
por: Guo, Jing, et al.
Publicado: (2021) -
The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019) -
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Dai, Congxin, et al.
Publicado: (2021) -
Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2020) -
Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
por: Xie, Weiyan, et al.
Publicado: (2016)